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A graphene oxide-Au NPs sensor platform combined with a multiple-enzyme labeled detection antibody-carbon sphere 
bioconjugate has been used as the basis for an ultrasensitive electrochemical immunosensor to detect the cancer biomarker, 
α-fetoprotein (AFP). Greatly enhanced sensitivity has been achieved by using the bioconjugates featuring horseradish 
peroxidase (HRP) and Ab2 linked to carbon nanospheres (Ab2-HRP-Au-PDA-carbon sphere) at a high ratio of HRP/Ab2. 
After a sandwich immunoreaction, the Ab2-HRP-Au-PDA-carbon sphere captured onto the electrode surface produces an 
amplified electrocatalytic response due to the reduction of enzymatically oxidized thionine in the presence of hydrogen 
peroxide. The increase of response current is proportional to the AFP concentration in the range of 0.01-20 ng/mL, with  
the detection limit of 3 pg/mL. This amplification strategy is a promising platform for detection of other proteins and 
clinical applications.  
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Immunoassays based on specific antigen-antibody 
recognition for analytical purposes have been an 
attractive subjected for clinical diagnosis1,2 
environmental analysis3, and the food industry4. 
α-fetoprotein(AFP), an oncofetal glycoprotein with a 
molecular mass of about 68 kDa5, is well-known as a 
tumor marker. In healthy human serum, the average 
concentration of AFP is typically below 25 ng/mL, 
and an elevated AFP concentration in adult plasma 
may be an early indication of some cancerous 
diseases including hepatocellular cancer, yolk sac 
cancer, liver metastasis from gastric cancer, testicular 
cancer, and nasopharyngeal cancer6. Thus, it is 
necessary to detect AFP for clinical diagnosis. Several 
methods and strategies such as fluorometry atomic 
studies7, absorption spectrometry8, and enzyme-linked 
immunoassay (ELISAs)9 have been reported for the 
determination of AFP. Electrochemical immunoassays 
seem to be excellent candidates for the rapid and 
inexpensive diagnosis of genetic diseases and for the 
detection of pathogenic biological species of clinical 
interest, due to their advantages such as simple 
pretreatment procedure, fast analytical time, precise 
and sensitive current measurements, and inexpensive 
and miniaturizable instrumentation10. Recently, 
numerous immunological methods for determining 
the concentration of AFP by electrochemical 
imunoassays have been reported11,12. In the development 
of electrochemical immunosensing strategies,  
the stability or activity of the immobilized 
biocomponents and signal amplification of the 
immunoconjugates are two key factors13. Attempts 
have been reported in the literature to improve 
the stability or activity of the immobilized 
biocomponents by using various novel materials 
such as organic-inorganic composite materials14, 
carbon nanotubes15, and other nanomaterials16. 
Carbon nanomaterials have attracted considerable 
attention in electrochemical biosensors because of 
their extraordinary physical properties and remarkable 
conductivities17. While CNTs have been widely used 
as labeling particles in immunoassays with excellent 
sensitivity, problems that need to be overcome 
include nanotube heterogeneity and purity. Recently, 
porous carbon nanospheres (CNSs) have also 
displayed unique advantages owing to the tunability 
of particle size and shape as well as the resident 
porosity that promotes diffusion of guest molecules 
through interconnected micropores18. A “green” 
synthetic approach has been developed that involves 




the transformation of sugars into homogeneous and 
stable colloidal CNSs, which are hydrophilic19,20. 
Such surface-functionalized CNSs and structures are 
potentially beneficial for labeling. 
For gold electrodes, the electrocatalytic properties 
strongly depend on their microstructure and surface 
chemistry. Recently, graphene has emerged as an 
interesting material because of its unusual electronic 
properties and large accessible surface area21,22. 
Biocompatible graphene sheets as a sensor platform 
not only present an abundant domain for bimolecular 
binding, but also exhibit fast electron-transfer kinetics 
and further signal amplification in electrochemical 
detection23,24. For example, a novel electrode system 
using reduced graphene oxide as a biosensing 
platform has been proposed. Graphene sheets are 
reported to show favorable electrochemical activity  
to several electroactive compounds25. In addition, 
graphene electrodes exhibit a superior biosensing 
performance over single-walled carbon nanotubes 
toward dopamine detection in the presence of 
common interfering agents, such as ascorbic acid and 
serotonin26. 
Herein, we report an electrochemical 
immunosensor for sensitive detection of AFP based 
on a dual amplification mechanism resulting from 
multienzyme-antibody functionalized CNSs and  
Au NPs functionalized graphene sheets as the sensor 
platform. The synthesized colloidal CNSs from 
glucose under hydrothermal treatment were employed 
as a carrier for HRP-secondary antibody (HRP-Ab2) 
immobilization. Greatly enhanced sensitivity was 
achieved by using the bioconjugates featuring 
horseradish peroxidase (HRP) and Ab2 linked to 
carbon nanospheres (Ab2-HRP-Au-PDA-carbon 
sphere) at a high ratio of HRP/Ab2. After a  
sandwich immunoreaction, the Ab2-HRP-Au-PDA-
CNSs captured onto the electrode surface produced an 
amplified electrocatalytic response by the reduction of 
enzymatically oxidized thionine in the presence of 
hydrogen peroxide. The increase of response current 
was proportional to the AFP concentration in the 
range of 0.01-20 ng/mL with the detection limit of  
3 pg/mL. The proposed immunosensor shows 
potential applications in clinical screening of cancer 
biomarkers and point of-care diagnostics. 
 
Materials and Methods  
Graphite flake (99.8%, 325 mesh) and DA 
hydrochloride (99%, F. wt. 189.64) was purchased 
from Alfa Aesar Co, (USA). AFP and anti-AFP were 
purchased from Biocell Co, (Zhengzhou, China). 
Bovine serum albumin (BSA), HRP, gold chloride 
(HAuCl4), and sodium citrate were obtained from 
Sigma Chemicals. (St. Louis, USA). All other 
reagents were commercially available. Phosphate 
buffer solution (0.1 M) of analytical grade (PBS, pH 7.4) 
was used as supporting electrolyte. All solutions were 
prepared with doubly distilled water. 
Scanning electron microscopy (SEM) images were 
obtained on a Quanta 200 scanning electron 
microscope (FEI, USA). UV-vis absorption spectra 
were recorded with a UV-2450 spectrophotometer 
(Shimadzu). Electrochemical experiments were carried 
out on a PGSTAT30/FRA2 system (Autolab, The 
Netherlands). A three-electrode system was used with a 
saturated calomel electrode (SCE) as the reference 
electrode, a platinum wire as the auxiliary electrode, 
and the modified AuE as the working electrode.  
 
Preparation of GO-Au NPs 
Au NPs were synthesized according to the  
as-reported method27. Briefly, 100 mL of 1 mM HAuCl4 
was brought to reflux while stirring and then 10 mL 
of 38.8 mM trisodium citrate solution was added 
quickly, which resulted in a color change of the 
solution from pale yellow to deep red. After the color 
change, the solution was refluxed for an additional  
15 min. The final concentration of Au NPs was fixed 
to 1 mM by evaporating excess water. 
The GO was prepared from graphite flake by 
Hummers’ method28. Briefly, 0.5 g of graphite, 0.5 g 
of NaNO3 and 23 mL of H2SO4 were stirred together 
in an ice bath. Next, 3 g of KMnO4 was gradually 
added under stirring, keeping the mixture below  
20 °C. Subsequently, the solution was transferred to a 
35±5 °C water bath and stirred for about 1 h, forming 
a thick paste. Next, 40 mL of ultrapure water  
was added. And the temperature was increased to 
90±5 °C, and stirred for 0.5 h. Finally, 100 mL of 
ultrapure water was added, followed by the slow 
addition of 3 mL of H2O2 (30%). It was observed that 
the color of the mixture changed from dark brown to 
yellow and there was no gas being produced. The 
warm solution was then filtered and washed three 
times with 5% aqueous HCl to remove metal ions and 
then washed with ultrapure water to remove the acid. 
The filter cake was dispersed in ultrapure water, and 
the obtained brown dispersion was then subjected to  
5 min of centrifugation at 3000 rpm to remove any 




unexfoliated graphite oxide. Exfoliation was obtained 
after 2 h of ultrasonic treatment.  
The preparation procedure of the GO-Au NPs 
hybrid is showed in Scheme 1. The GO were first 
functionalized with PDDA by the following 
procedure. A 3 mL portion of 1 mg/mL GO was 
dispersed in 12 mL of aqueous solution containing 
0.625 M potassium chloride and 1.25 mg/mL PDDA. 
After being mixed well, the mixture was sonicated for 
3 h to give a homogeneous black dispersion. Excess 
PDDA was removed by centrifugation, and the 
composite was rinsed with water twice. Finally, the 
PDDA/GO was redispersed in 3 mL of water. A  
200 μL portion of 1 mg/mL PDDA/GO was added to 
4 mL of Au NPs solution under stirring. Then, the 
mixture was sonicated for 2 min before standing 
overnight. Finally, the precipitate was collected by 
centrifugation and washed several times. The  
as-prepared GO-Au NPs mixture was redispersed in  
1 mL of water. 
 
Preparation of Ab2-HRP-Au-PDA-carbon sphere conjugate 
Carbon sphere was synthesized from glucose in 
closed systems under hydrothermal conditions and 
characterized by electron imaging studies (SEM)29. 
Briefly, 8 g of glucose was dissolved in water  
(30 mL). After being mixed well, the mixture was 
sonicated for 0.5 h to form a clear solution, which was 
placed in a 40 mL teflon-sealed autoclave and 
maintained at 160 °C for 7 h. The puce products were 
isolated by centrifugation, cleaned by three cycles of 
centrifugation/washing/redispersion in water and in 
alcohol, and oven-dried at 80 °C for more than 4 h.  
For synthesis of Ab2-HRP-Au-PDA-carbon sphere 
conjugate, HRP and Ab2 were attached to carbon 
sphere with a reaction mixture of 300/1 HRP/Ab2 
molar ratio (Scheme 2). Briefly, 500 μL of 60 mM 
(excess) DA, 0.25 mg HRP and 8 μg Ab2 were added 
to 1.0 mL PBS containing 0.5 mg mL-1 carbon sphere 
under vigorous stirring at 4 °C. Then, 300 μL of 2% 
HAuCl4 was added dropwise to the mixture and the 
reaction mixture was stirred for 20 min to allow for 
completion of the reaction to form Ab2-HRP-Au-
PDA-carbon sphere conjugate. After that, the reaction 
mixture was washed with PBS and centrifuged at 
13000 rpm for 5 min three times, and the supernatant 
was discarded. The resulting mixture was redispersed 
in 1.0 mL of pH 7.4 PBS containing 1% BSA and 
stored at 4 °C when not used. The Ab2-HRP-Au-
PDA-carbon sphere conjugate is stable and can keep 
enzyme activity for at least one month.  
 
 





Preparation of Ab2- HRP–Au-PDA-carbon sphere conjugate 
 
Scheme 2




Fabrication of the immunosensor 
The gold electrode (AuE, 2-mm diameter) was 
carefully polished by 1.0, 0.3, and 0.05 μm alumina 
slurry, respectively, with thorough rinsing with 
doubly distilled water between each polishing step. 
The electrode was ultrasonically cleaned with 1:1 
nitric acid, ethanol, and doubly distilled water, and 
then allowed to dry under N2. Then, a 5 μL of GO-Au 
NPs Hybrid was cast on a pretreated Au electrode and 
dried at room temperature. The AuE/GO-Au NPs was 
immersed in 0.5 mL phosphate buffer solution  
(pH 7.4) with Ab1(0.50 mg/mL) solution at 4 °C for 
6 h. The antibody-embedded glod electrode (denoted 
as AuE/GO-Au NPs/ Ab1) was soaked in 1% BSA 
solution for 1 h at 37.5 °C to block the non-specific 
sites (denoted as AuE/GO-Au NPs/ Ab1/BSA). Then 
AuE/GO-Au NPs/ Ab1/BSA was rinsed in doubly 
distilled water to remove the redundant amount of 
BSA. The resulting electrode was stored in the 
phosphate buffer solution (pH 7.4) at 4 °C until 
further use. 
 
Immunoassay procedure for detection of AFP  
A sandwich immunoassay was used for 
determination of AFP. The immunosensor, AuE/GO-
Au NPs/ Ab1/BSA, was incubated with 0.50 mL of a 
different concentration of AFP standard antigen for  
35 min, followed by washing with doubly distilled 
water and PBS buffer. Next, the electrode (AuE/GO-
Au NPs/Ab1/BSA/AFP) was incubated with 10 μL of 
Ab2-HRP -Au-PDA-carbon sphere dispersion for  
60 min, followed by washing with doubly distilled 
water and PBS buffer to remove the non-specific 
adsorption of conjugate. The electrochemical 
detection was performed in a PBS buffer solution 
containing 50 μM thionine and 4 mM H2O2. 
Schematic illustration of the multienzyme labeling 
amplification strategy using Ab2-HRP-Au-PDA-
carbon sphere conjugate is shown in Scheme 3. 
 
Results and Discussion  
 
Characterization of GO-Au NPs 
The entire process of self-assembly of GO and Au 
NPs is shown in Scheme 1. The cationic functional 
macromolecules of PDDA were adsorbed at the GO, 
which resulted in positive charges on the surface of 
GO. Finally, the cationic GO dispersion was directly 
mixed with the as-prepared solution of Au NPs. 
Driven by the electrostatic interaction, the citrate-
capped Au NPs quickly adhered to the surface of 
PDDA/GO. The typical SEM images of GO and  
as-prepared GO-Au NPs hybrids are displayed in  
Fig. 1. As shown in Fig. 1(a), thin films of oxidizing 
graphite was observed. After the formation of GO-Au 
NPs hybrids, it is observed that all the GO nanosheets 
have been decorated with NPs and nearly all the Au 
NPs were distributed uniformly at the surface of  
the GO (Fig. 1(b)), suggesting that the present  
self-assembly method can effectively produce 
homogeneous high-loading NPs supported on  












UV-vis absorption spectra of the GO and GO-Au 
NPs hybrids are shown in  Fig. 2.  Pure GO  with  two 
characteristic absorption peaks at 230 and 300 nm 
originating from π-π* transition of the C=C band and 
n-π* transition of the C=O band,30 respectively are 
observed. Compared with the spectrum of purified 
GO (Fig. 2, curve 1), a new UV-vis absorption peak 
of GO-Au NPs hybrids appeared at ca. 530 nm  
(Fig. 2, curve 2), which indicates the capture of 
AuNPs 31. The result suggests that some of the 
surface-modified AuNPs are in close proximity with 
each other, but were not agglomerated, as evidenced 
by the SEM images. 
UV-vis absorption spectra of the carbon 
nanospheres and the Ab2-HRP-Au-PDA-carbon 
sphere Conjugate are shown in Fig 3. Compared  with 
the spectrum of pure colloidal carbon spheres (Fig. 3, 
curve 1), two new absorption bands centered at  
280 nm and 560 nm were observed in the spectrum of 
the Ab2-HRP-Au-PDA-carbon sphere conjugate  
(Fig. 3, curve 2). An intense band was observed at 
281 nm, which is directly related to the symmetry-
forbidden transitions (La-Lb) of the DA molecule32. 
The absorption bands centered at 560 nm and  
can be ascribed to the production of AuNPs from  
the reduction of HAuCl4 by DA in the 
bionanocomposites. The shift in the resonance 
wavelength is attributed to interparticle plasmon 
coupling, a phenomenon observed even when just a 
few Au NPs or nanorods were clustered together33. 
The result suggests that some of the surface-modified 
AuNPs were in close proximity with each other  
but were not agglomerated, as evidenced by the  
TEM images.  
 
Signal amplification immunoassay with Ab2-HRP-Au-PDA-
carbon sphere conjugate 
To enhance detection sensitivity, herein we 
pursued a multienzyme labeling strategy instead of a 
 
 
Fig. 2—UV–vis absorption spectra of GO (1), and, GO-Au NPs 
composites (2) in water. 
 
 
Fig. 1—SEM images of (a) GO and (b) GO-Au NPs hybrids. 
 
 
Fig. 3—UV–vis absorption spectra of carbon nanosphere (1), and, 
Ab2-HRP -Au-PDA-carbon sphere conjugate (2) in water. 




single-enzyme label during the immunoassay. As 
shown in Fig. 4, the cyclic voltammogram at 
AuE/GO-Au NPs /Ab1/BSA/AFP/Ab2-HRP-Au-
PDA-carbon sphere electrode (Fig. 4, curve 1) did not 
show any detectable signal in pH 7.4 PBS. Upon 
adding 0.05 mM thionine to the PBS buffer, the cyclic 
voltammogram exhibited a pair of stable and well-
defined redox peaks (Fig. 4, curve 2), corresponding 
to the electrochemical oxidation and reduction of 
thionine. However, after adding 4 mM H2O2 to the 
PBS buffer, the electrocatalytic current at AuE/GO-
AuNPs/Ab1/BSA/AFP/Ab2-HRP-Au-PDA-carbon sphere 
electrode increased significantly (Fig. 4, curve 3). It is 
not surprising that the multienzyme-antibody labeling 
strategy enhanced the detection signal more than the 
traditionally labeled HRP-Ab2. The achieved 
amplification of signal is ascribed to the large amount 
of enzymes loaded on the carbon sphere nanocarrier. 
 
EIS characterization of the immunosensor 
It is well known that EIS is an excellent technique 
for investigating the interface properties of surface-
modified electrodes. A typical impedance spectrum 
(presented in the form of the Nyquist plot) exhibits a 
semicircle near the origin at higher frequencies 
corresponding to the electron-transfer-limited process 
and a linear tail at lower frequency range representing 
the diffusion-limited process. The electron-transfer 
resistance, Ret, is the most directive and sensitive 
parameter that responds to changes on the electrode 
interface, as represented by the diameter of the 
semicircle in the Nyquist plot. Figure 5 shows the 
impedance spectra corresponding to the stepwise 
modification processes. The bare electrode exhibited 
an almost straight line that is characteristic of a 
diffusional limiting step of the electrochemical 
process (Fig. 5, curve 1). When the electrode was 
modified with GO-Au NPs, the GO-Au NPs/Au 
electrode exhibited a small semicircle at high 
frequencies (Fig. 5, curve 2), i.e., a low resistance on 
the GO-Au NPs modified electrode, indicating the 
successful formation of GO-Au NPs film on the 
electrode surface. After Ab1 molecules were attached 
to the GO-Au NPs film, a remarkable increase of the 
semicircle diameter was observed (Fig. 5, curve 3), 
and a further increase was noticed (Fig. 5, curve 4) 
when the Ab1/GO-Au NPs /Au electrode was blocked 
with BSA. The above results clearly confirm that Ab1 
and BSA were successfully immobilized on the 
electrode. The Ret increased again after the prepared 
immunosensor was incubated with AFP solution. 
When the prepared immunosensor was incubated with 
HBsAg solution, the formed antigen-antibody 
immunocomplex formed on the film would further 
hinder the access of the redox probe to the electrode. 
Then the resistance increased when Ab2-HRP-Au-
PDA-carbon sphere were further incubated with  
Ab2-HRP-Au-PDA-carbon sphere bioconjugate  
(Fig. 5, curve 6), which proved that Ab2-HRP-Au-PDA-
carbon sphere bioconjugate was also successfully 
immobilized on the electrode. The EIS change of the 
modified process indicates that the AuE/GO-Au 
NPs/Ab1/BSA/AFP/Ab2-HRP-Au-PDA-carbon sphere 
composite film was successfully formed on electrode 
surface and suitable for immunosensing. 
 
 
Fig. 4—Cyclic voltammograms obtained at CVs of the AuE/
GO-Au NPs/Ab1/BSA/AFP/Ab2-HRP–Au-PDA-carbon sphere 
electrode in pH 7.4 PBS (curve 1), pH 7.4 PBS containing 
0.05 mM THI (curve 2), and, pH 7.4 PBS containing 0.05 mM




Fig. 5—EIS of the different electrodes. [(1) bare electrode; 
(2) GO-Au NPs; (3) GO-Au NPs/anti-AFP; (4) GO-Au NPs/anti-
AFP/BSA; (5) electrode (4) incubated with 1 ng mL-1 AFP; 
(6) electrode (5) incubated with Ab2-HRP-Au-PDA-carbon sphere
in the presence of the redox couple of Fe(CN)6 
3-/4- containing 
0.10 mol L-1 KCl]. 




Optimization of detection conditions  
The H2O2 concentration in 5 mL of pH 7.4 PBS 
buffer on the steady-state current of the immunosensor 
was studied as it played an important role in the 
immunosensor performance. When the H2O2 
concentration was less than 4 mM, the reduction peak 
current increased linearly with increasing H2O2 
concentration, and then tended towards a constant value, 
which corresponded to the saturated station. This shows 
that the HRP attached to the immunosensor surface had 
a relatively high catalytic activity. Therefore, the optimal 
concentration of H2O2 was chosen at 4 mM. 
At room temperature, the amperometric responses 
for AFP increased with the increasing incubation time 
used in sandwich-type immunoassay and then tended 
to constant values after 35 min, which showed a 
saturated binding between the analyte and the capture 
antibody on electrode surface. Therefore, 35 min of 
incubation time was selected for the sandwich-type 
immunoassay. 
Due to the co-immobilization of enzymes and 
antibodies on the carbon sphere nanocarrier, the ratio 
of HRP and Ab2 (HRP/Ab2) is the most important 
factor on the response signal. The electrocatalytic 
current increased with increasing the ratio of 
HRP/Ab2, and the maximum response was achieved 
at the ratio of 300:1. The increase of the HRP/Ab2 
ratio could increase the total amount of HRP loaded 
per carbon sphere nanocarrier, which is expected to 
enhance the response amplification for this sandwich 
immunoassay. However, the reducing amount of Ab2 
in the immunoassay may decrease immunocoupling 
efficiency to the captured AFP antigen at the 
electrode surface, which may result in a decreased 
response. Therefore, the HRP/Ab2 ratio of 300:1 was 
selected as the optimal condition to prepare the  
Ab2-HRP-Au-PDA-carbon sphere conjugate. 
The effect of the immunochemical incubation 
temperature (i.e., when the antigen-antibody reaction 
occurs) was examined at the range from 15-45 °C. It 
was found that the current response increased with 
increasing temperature up to 37 °C. The lower 
response at the incubation temperatures higher than 
37 °C may be attributed to an irreversible behavior 
(denaturation of proteins) involved in the process. 
Therefore, 37 °C of incubation temperature was 
selected for the sandwich-type immunoassay. 
 
Analytical performance 
Under the optimum conditions, the peak currents of 
the immunosensor array for simultaneous detection of 
AFP increased with the increasing concentration of 
analytes (Fig. 6). The calibration plots show good 
linear relationships between the peak currents and the 
logarithm of the analyte concentrations in the ranges 
from 10 pg/mL to 20 ng/mL with a correlation 
coefficient of 0.9942 (n = 6) for AFP. The limits of 
detection for AFP was 3 pg/mL at a signal-to-noise 
ratio of 3. The achieved high sensitivity mainly  
results from the excessive enzymes present in the 
carbon sphere. 
The selectivity of the electrochemical 
immunoassay was studied using blank PBS and other 
proteins such as CEA (1 ng/mL), HBsAg (1 ng/mL) 
and BSA (1 ng/mL). Results clearly show that the 
sensor response is directly from the binding of AFP to 
anti-AFP and the level of sensor response depends on 
the AFP concentration. 
 
Conclusions 
In this work, we have successfully developed a 
highly sensitive and selective immunosensor for 
detecting cancer biomarkers and demonstrated this 
signal amplification procedure. The greatly enhanced 
sensitivity relies upon two merits: (1) carbon sphere 
as the enzyme-loading carrier can load many enzyme 
molecules on each carbon sphere. The labeling 
protocol allows multiple signals per binding event 
provided by the use of Ab2-HRP-Au-PDA-carbon 
sphere instead of conventional HRP-Ab2. (2) GO-Au 
NPs can provide a high density of primary antibodies 
because of their high surface area. The resulting 
 
Fig. 6—DPV curves of the immunosensor after incubating with 
various concentrations of AFP (0, 0.01, 0.05, 0.1, 0.5, 1, 5, 10, 
and 20 ng mL-1 from bottom to top). [Inset: calibration curve of 
the immonosensor for AFP determination]. 




immunosensor possesses high sensitivity, good 
reproducibility, and cost-effective analytical 
performance. This method can be expanded for 
detecting other relevant biomarkers and has the 
potential for reliable point-of-care diagnostics of 
cancer and other diseases. 
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